☆ 4.7 Article

Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination

SCIENTIFIC REPORTS (2023)

Related references

Note: Only part of the references are listed.

Review Immunology

T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses

Elahe Aleebrahim-Dehkordi et al.

Summary: Cytokines produced by T helper cells play crucial roles in host defense against viruses, with Th1 cells essential for defense against intracellular pathogens and Th2 cells critical for parasite elimination. Diseases caused by SARS-CoV-2 and H1N1 influenza have led to global epidemics, with pulmonary immunopathology being a leading cause of mortality. Inadequate or excessive levels of specific cytokines can have adverse effects on the body during these viral infections.

TRANSPLANT IMMUNOLOGY (2022)

Add to Collection

Article Cell Biology

Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice

Cecilia B. Cavazzoni et al.

Summary: This study reveals the roles of follicular helper T cells (Tfh cells) and follicular regulatory T cells (Tfr cells) in the germinal center (GC) reactions after SARS-CoV-2 spike protein vaccination. Tfh cells promote the frequency and somatic hypermutation (SHM) of Spike-specific GC B cells, while Tfr cells control SHM and clonal diversity in the GC by limiting clonal competition.

CELL REPORTS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms

Ameneh Jafari et al.

Summary: This article provides an overview of key strategies for developing SARS-CoV-2 vaccine candidates, discussing the mechanism of action, advantages, and potential limitations of each vaccine, as well as the application of nanomaterials and nanotechnology in COVID-19 vaccine development.

MOLECULAR BIOLOGY REPORTS (2022)

Add to Collection

Article Immunology

Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses

Jeffrey A. Tomalka et al.

Summary: Host genetic and environmental factors play a significant role in vaccine-induced immune responses. Understanding and accounting for these factors are crucial for the development of effective vaccines against SARS-CoV-2.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Microbiology

Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19

Wei Zhao et al.

Summary: This study reported the long-term persistence of antibodies and cellular responses within 12 months after two doses of CoronaVac vaccine. The results showed that binding and neutralizing antibodies could be detected at 1 month after vaccination and remained detectable at significantly higher levels than baseline at 12 months. In addition, the study found that CoronaVac induced functional SARS-CoV-2-specific CD4(+) and CD8(+) memory T cells, which persisted up to 12 months after vaccination.

MBIO (2022)

Add to Collection

Article Immunology

An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)

Zhujun Jiang et al.

Summary: By analyzing peripheral blood cells from CoronaVac-vaccinated individuals and COVID-19 recovered patients, researchers found that the vaccine can significantly increase SARS-CoV-2 neutralizing antibody levels and induce changes in immune cell responses. After vaccination, type-1 helper T cells (Th1) and antibodies dominate humoral immune responses, while T follicular helper cells (Tfh) are involved in antibody production. Additionally, multi-omics analysis of vaccinated and recovered individuals identified specific changes in serum proteins, metabolites, and lipids. These findings provide a comprehensive understanding of the in vitro immune features specific to CoronaVac.

VACCINES (2022)

Add to Collection

Article Multidisciplinary Sciences

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

Jaime S. Rosa Duque et al.

Summary: This study compares the immunogenicity and reactogenicity of two widely available SARS-CoV-2 vaccines, BNT162b2 (an mRNA vaccine) and CoronaVac (a whole-virus inactivated vaccine), in healthy adolescents. The results show that the antibody and T cell immune responses in adolescents receiving two doses of either BNT162b2 or CoronaVac are similar to those seen in adults receiving two doses of the same vaccine. However, the immune response to a single dose of BNT162b2 in adolescents is not as robust. Additionally, CoronaVac induces a higher proportion of adolescents to have positive antibody responses compared to adults. Adverse reactions are generally mild for both vaccines, with BNT162b2 having slightly more frequent adverse reactions.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19

Marina Mazzilli Ortega et al.

Summary: We investigated the immune response to the SARS-CoV-2 vaccine (CoronaVac) in healthcare workers who had received two doses of the inactivated virus-based vaccine. Our study analyzed serum and salivary antibodies, serum antibody neutralizing activity, and cellular immune response. The results showed that CoronaVac induced the production of specific serum and saliva antibodies, as well as IFN-gamma producing T cells, in most individuals who had recovered from COVID-19 and/or were vaccinated. The vaccine demonstrated neutralizing activity against the ancestral strain, but a reduced response against the variants. Vaccinated individuals with previous COVID-19 infection exhibited higher immune responses compared to those without previous infection.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J. Ewer et al.

Summary: A single dose of the ChAdOx1 nCoV-19 vaccine can induce favorable immune responses that may help control or prevent SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella et al.

Summary: BBV152 vaccine, consisting of whole-virion inactivated SARS-CoV-2 with Algel and IMDG, showed high neutralizing antibody responses in phase 1 trial and better reactogenicity in phase 2 trial. The 6 mu g with Algel-IMDG formulation has been chosen for phase 3 efficacy trial.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Geriatrics & Gerontology

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

Istvan Valyi-Nagy et al.

Summary: This study compared the humoral and T cell-mediated immune responses elicited by BBIBP-CorV and BNT162b2 vaccines against the SARS-CoV-2 virus, revealing significant quantitative and qualitative differences between the two. BBIBP-CorV vaccine induced high levels of antibody responses in healthy individuals, while BNT162b2 showed slightly higher T cell responses.

GEROSCIENCE (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351

Xiaoying Shen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization

Guo-Lin Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection

Zhongfang Wang et al.

Summary: The study found virus-specific T-cell memory in COVID-19 patients and close contacts. Patients had stronger T cell responses compared to close contacts. Despite lacking detectable infection, close contacts were able to gain T-cell immunity against SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Chemistry, Medicinal

COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials

Zhi-Peng Yan et al.

Summary: Various strategies, including vaccine development, have been designed to contain the COVID-19 pandemic. This study reviews the most recent data of 12 vaccines to evaluate their efficacy, safety profile, and usage in various populations, highlighting the importance of comparing protective efficacy and risks of vaccination for global control through herd immunity.

PHARMACEUTICALS (2021)

Add to Collection

Article Cell Biology

Functional responsiveness of memory T cells from COVID-19 patients

Ece Tavukcuoglu et al.

Summary: The study found that memory T cells from individuals with a history of COVID-19 possess functional capacities to reinvigorate anti-viral immunity against SARS-CoV-2, demonstrating enhanced proliferation capacity and secretion of key immune proteins.

CELLULAR IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

Mark M. Painter et al.

Summary: The study found that after SARS-CoV-2 mRNA vaccination, CD4(+) T cell responses in naïve individuals were fast, while CD8(+) T cell responses developed gradually. Th1 and Tfh cell responses after the first dose were correlated with post-boost CD8(+) T cells and neutralizing antibodies.

IMMUNITY (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanriover et al.

Summary: The study presented the interim efficacy and safety results of the CoronaVac vaccine in a phase 3 clinical trial in Turkey, demonstrating high efficacy against PCR-confirmed symptomatic COVID-19 with good safety and tolerability profile. Results showed significant differences in the frequency of any adverse events between the vaccine and placebo groups, indicating excellent protective effects of the vaccine.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells

Jae Hyung Jung et al.

Summary: The study reveals that memory T cell responses can be detected in convalescent COVID-19 patients up to 317 days post-symptom onset, indicating potential long-lasting immunity, especially with the presence of stem cell-like memory T cells.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Immunology

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants

Daniel Martinez-Flores et al.

Summary: COVID-19, caused by SARS-CoV-2, affects the respiratory system and has resulted in over 2 million deaths worldwide. Vaccines targeting the S glycoprotein have been developed, but the emergence of new variants could impact their effectiveness.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

After the pandemic: perspectives on the future trajectory of COVID-19

Amalio Telenti et al.

Summary: This article discusses the future patterns of SARS-CoV-2 infection, the development of variants, and the implications for vaccine deployment. It suggests that the virus may become endemic fueled by pockets of susceptible individuals and waning immunity. Effective surveillance and response are crucial to prevent new epidemic or pandemic patterns.

NATURE (2021)

Add to Collection

Review Immunology

Viral targets for vaccines against COVID-19

Lianpan Dai et al.

Summary: The urgent need for vaccines to control the COVID-19 pandemic has led to the rapid development of multiple vaccine candidates, with some showing positive results in late-stage clinical trials. This article discusses the viral elements used in these candidates, the reasons why they are good targets for the immune system, and their implications for protective immunity. Dai and Gao highlight the importance of selecting the right viral targets in vaccine development to ensure an effective immune response and the overall safety and efficacy of the vaccine.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Add to Collection

Review Immunology

The Role of PD-1 in Acute and Chronic Infection

Jil M. Jubel et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang et al.

CELL (2020)

Add to Collection

Article Medicine, Research & Experimental

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Alessio Mazzoni et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Virology

Surprisingly Effective Priming of CD8+ T Cells by Heat-Inactivated Vaccinia Virus Virions

Sarah Croft et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

COVID-19 Makes B Cells Forget, but T Cells Remember

Pablo F. Canete et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Robert Lorenz Chua et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Divij Mathew et al.

SCIENCE (2020)

Add to Collection

Review Virology

COVID-19 Vaccine: A comprehensive status report

Simran Preet Kaur et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov et al.

LANCET (2020)

Add to Collection

Article Immunology

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Gemma E. Hartley et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Immunological considerations for COVID-19 vaccine strategies

Mangalakumari Jeyanathan et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Immunology

T cell responses in patients with COVID-19

Zeyu Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Review Immunology

Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses

Maria Auladell et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

The effect of antigen dose on T cell-targeting vaccine outcome

Rolf Billeskov et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Add to Collection

Article Immunology

The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses

Ewa Oleszycka et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Review Immunology

Understanding Subset Diversity in T Cell Memory

Stephen C. Jameson et al.

IMMUNITY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The untold story of IFN-γ in cancer biology

M. Alper Kursunel et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

Add to Collection

Review Multidisciplinary Sciences

The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm

Tirth Raj Ghimire

SPRINGERPLUS (2015)

Add to Collection

Article Cell Biology

IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function

Jan P. Boettcher et al.

CELL REPORTS (2014)

Add to Collection

Review Immunology

T cell responses to viral infections - opportunities for peptide vaccination

Sietske Rosendahl Huber et al.

FRONTIERS IN IMMUNOLOGY (2014)

Add to Collection

Review Immunology

Mechanism of immunopotentiation and safety of aluminum adjuvants

Harm HogenEsch

FRONTIERS IN IMMUNOLOGY (2013)

Add to Collection

Review Immunology

Mechanisms of action of adjuvants

Sunita Awate et al.

FRONTIERS IN IMMUNOLOGY (2013)

Add to Collection

Review Immunology

T-cell quality in memory and protection: implications for vaccine design

Robert A. Seder et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Add to Collection

Review Immunology

Central memory and effector memory T cell subsets: Function, generation, and maintenance

F Sallusto et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.